Clinical Trials Browser

Phase NA × Nasopharyngeal Carcinoma × Surgical Procedures, Operative × Clear all

NCT05352321 2022-07-01

Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma

Phase NA Recruiting

Nasopharyngeal Carcinoma